Antisense-mediated splice intervention represents a promising therapeutic strategy for rare neuromuscular disorders, though clinical translation requires non-conventional trial designs and multidisciplinary collaboration.
No takes yet. Share an insight, caveat, or question.
May expand antisense splice modulation to common diseases; leaves open clinical validation in larger trials.
Fletcher et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: